Plain-English translation of NCT06264934 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →Researchers are testing a new device called the Z-scanner that measures how breast tissue stores electrical energy. Cancer tissue behaves differently electrically than healthy tissue, and this study will help determine whether the Z-scanner can reliably detect the difference between healthy breast tissue, benign lumps, and cancer.
Breast cancer is the most common cancer in women worldwide, and current detection methods have limitations. This research explores whether measuring electrical properties could become a new, non-invasive way to help identify cancerous tissue earlier and more accurately.
If you enroll, you will have both of your breasts scanned with the Z-scanner during your regular clinic visit—the scan itself is painless and non-invasive. The study is divided into two parts: the first group of 20 women will help researchers confirm the scanner works reliably, and the second group of 70 women (with known benign or cancerous lesions) will help show whether the scanner can actually tell the difference between healthy, benign, and cancerous tissue. The entire scan should take only a short time as part of your appointment.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United Kingdom